Back
 
Name: Dr. Gul Shahnaz
Designation: Assistant Professor
Department: Pharmacy


Qualifications: PhD (Pharmaceutical Technology) Austria, Post Doc (USA)


Phone: +92-51 9064-4137
Email: gshahnaz@qau.edu.pk
Status: On job
Other Weblink: https://scholar.google.com.pk/citations?user=KaTRdF4AAAAJ&hl=en

View Resume

Research Interests Publications Conferences Research Projects

Targeted Nanomedicine for Infectious Diseases
Cancer Nanotherapeutics


M. Phil Supervision

S.No

Student’s Name

Thesis title

Year

1.

Fatima Balquis

Evaluating the Potential of Private Pharmacies to Circumvent the Tuberculosis Burden

2017

2.

Azhar Hussain Tahir 

Exploration of health care professionals’ involvement and attitudes toward alternative medicines

2017

3.

Rabia Arshad

Development and characterization of thiolated bandage for post-operative surgical site infections

2017

4.

Iqra Afzal

Targeted mannosylated nanoparticles for Paromomycin delivery in leishmaniasis therapy

2017

5.

Bushra

Nawaz Cheema

Evaluation of wound vaccination services in community pharmacies

2017

6.

Sidra Butt

Comparative analysis for the effectiveness of   combinatory antihypertensive therapy in clinical setting of Pakistan

2017

7.

Tehniat Zahra

Parental vaccine hesitancy as a barrier for immunization coverage rate 

2017

8.

Beenish Ashfaq

Prevalence of airborne allergens in Pakistan and association of trigger factor with allergenic diseases

2017

9.

Hajra Zafar

 

Amoxicillin loaded mucoadhesive thiomer based nanoparticles  for H.pylori infection therapy

2017

10.

Iqra Chaudhery

 

Development of long-acting enema for intracolonic administration of vancomycin in lieu of pediatric infectious colitistherapy

2017

11.

Uswa Rasheed

Malnutrition in surgical patients: Evaluation of pre- and postoperative outcomes and effectiveness of nutritional screening tools

2018

12.

Sara Shahid

Impact of Educational Intervention regarding Metered Dose Inhaler Technique on Pharmacists and Asthma Patients

2018

13.

Asma kanwal

Formulation and evaluation of thiolated mucoadhesive composite polymeric periodontal membrane of doxycycline

2018

14.

Sundus Maria

Synthesis and characterization of nanoparticles based on preactivated thiolated chitosan for oral delivery of octreotide

2019

15.

Ayesha Batool

Formulation and evaluation of mucoadhesive self nanoemulsifying drug delivery system (snedds) for tamoxifen

2019

16.

Muhammad Shakeel

Synthesis and evaluation of thiolated emulgel based silver nanoparticles for cutaneous leishmaniasis

2019

17.

Sumbal Sohail

Educational intervention for Tuberculosis Prevention by health belief model

 

18.

Muska

Management of maternal antenatal associated insomnia and anxiety during pregnancy: pharmacist led implementation of cognitive behavioral therapy

 

PhD Supervision

1.

Muhammad Farhan Sohail

 

Design, synthesis and characterization of targeted thiolated nanocargoes in cancer therapy

2017

2.

Hafiz Shoaib Sarwar

Formulation and Evaluation of Macrophage Targeted Thiolated Nanocarriers for the Enhanced Efficacy of Anti-Leishmanial Drugs

2019


               

 

Authors/Title of Research Paper

(Impact Factor 175)

Journal Name/ISSN

Volume (Issue No): Page No

(Year)

Category

W/X/Y/Z

(Impact

Factor)

1.      Development and Evaluation of Optimized Thiolated Chitosan Proniosomal Gel Containing Duloxetine for Intranasal Delivery. khatoon M, Sohail MF, Shahnaz G, Rehman F, Din FU, Rehman Au.

 

2.      ZnO-NPs embedded biodegradable thiolated bandage for postoperative surgical site infection: in vitro and in vivo evaluation. Arshad R, Sohail MF, Sarwar HS, Saeed H, Ali I, Akhtar S, Hussain SZ, Afzal A, Jehan J, Rehman A and Shahnaz G.

AAPS PharmSciTech.  ISSN: 1530-9932

18(4):1043-1055.

2019

 

PLOS ONE

ISSN: 1932-6203

(2019)

W

2.6

 

 

 

 

2.8

3.      Drug Delivery System (SNEDDS) for Improved Oral Bioavailability of Chlorpromazine: In Vitro and In Vivo Evaluation Baloch J, Sohail MF, Sarwar HS, Kiani MH, Khan GM, Jahan S, Rafay M, Chaudhry MT, Yasinzai M, Shahnaz G. Self-Nanoemulsifying.

Medicina (Kaunas).

ISSN: 1010-660X

 May 24;55(5).

(2019)

W

1.42

4.      Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis. Afzal I, Sarwar HS, Sohail MF, Varikuti S, Jahan S, Akhtar S, Yasinzai M, Satoskar AR, Shahnaz G.

Nanomedicine (Lond).

ISSN: 1743-5889

Feb;14(4):387-406

(2019)

W

     4.727

5.      Folate-Functionalized Thiomeric Nanoparticles for Enhanced Docetaxel Cytotoxicity and Improved Oral Bioavailability Sajjad M, Khan MI, Naveed S, Ijaz S, Qureshi OS, Raza SA, Shahnaz G, Sohail MF..

AAPS PharmSciTech.

ISSN: 1530-9932

Jan 15;20(2):81.

(2019)

W

     2.6

 

6.      Evaluation of Turmeric Nanoparticles as Anti-Gout Agent: Modernization of a Traditional Drug Kiyani MM, Sohail MF, Shahnaz G, Rehman H, Akhtar MF, Nawaz I, Mahmood T, Manzoor M, Bokhari SAI. .

Medicina (Kaunas).

ISSN: 1010-660X

 Jan 11;55(1)

(2019)

W

1.42

7.      Polymeric nanocapsules embedded with ultra-small silver nanoclusters for synergistic pharmacology and improved oral delivery of Docetaxel Sohail MF, Hussain SZ, Saeed H, Javed I, Sarwar HS, Nadhman A, Huma ZE, Rehman M, Jahan S, Hussain I, Shahnaz G..

Sci Rep.

ISSN: 2045-2322.

Sep 6;8(1):13304. (2018)

W

     4.6

8.      Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends.Sohail MFRehman MSarwar HSNaveed SSalman OBukhari NIHussain IWebster TJShahnaz G.

Int  J Nanomedicine.

ISSN: 1178-2013

Jun 8;13:3145-3161

(2018)

W

     4.543

9.      Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis.Sarwar HS, Sohail MF, Saljoughian N, Rehman AU, Akhtar S, Nadhman A, Yasinzai M, Gendelman HE, Satoskar AR, Shahnaz G.

Artif Cells Nanomed Biotechnol.

ISSN: 21691401

Jan 31:1-11. (2018)

 

W

5.6

10.               Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis. Sarwar HS, Ashraf S, Akhtar S, Sohail MF, Hussain SZ, Rafay M, Yasinzai M, Hussain I, Shahnaz G.

Nanomedicine (Lond).

ISSN: 1743-5889

Jan;13(1):25-41

(2018)

 

W

     4.727

11.               Biosynthesized colloidal silver mand gold nanoparticles as emerging leishmanicidal agents: an insight. Ovais M, Nadhman A, Khalil AT, Raza A, Khuda F, Sohail MF, Islam NU, Sarwar HS, Shahnaz G, Ahmad I, Saravanan M, Shinwari ZK.

Nanomedicine (Lond).

ISSN: 1743-5889

12(24):2807-2819.

(2017)

 

 

W

     4.727

12.               Redox biology of Leishmania and macrophage targeted nanoparticles for therapy Sarwar HS, Akhtar S, Sohail MF, Naveed Z, Rafay M, Nadhman A, Yasinzai M, Shahnaz G..

Nanomedicine (Lond).

12(14):1713-1725

(2017)

 

W

     4.727

13.               Cell to rodent: toxicological profiling of folate grafted thiomer enveloped nanoliposomes, Sohail MF, Sarwar HS, Javed I, Nadhman A, Hussain SZ, Saeed H, Raza A, Bukhari NI, Hussain I, Shahnaz G

Toxicol. Res.

ISSN:19768257

6, 814-821

(2017)

 

W

     1.969

14.               Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis Shahnaz G, Edagwa BJ, McMillan J, Akhtar S, Raza A, Qureshi NA, Yasinzai M, Gendelman HE..

Nanomedicine (Lond).

12(2):99-115.

(2017)

 

W

     4.727

15.               Formulation and in Vitro Characterization of Thiolated Buccoadhesive Film of Fluconazole Naz K, Shahnaz G, Ahmed N, Qureshi NA, Sarwar HS, Imran M, Khan GM..

AAPS PharmSciTech.

ISSN: 1530-9932

18(4):1043-1055.

(2017)

 

W

     2.451

 

16.               In-vitro antileishmanial potential of peptide drug hirudin.Khan H, Nadhman A, Azam SS, Anees M, Khan I, Ullah I, Sohail MF, Shahnaz G, Yasinzai M.

Chem Biol Drug Des.

ISSN: 1747-0285

89(1):67-73.

(2017)

 

W

     2.39

 

17.               Rise of single organopathy theory from ayurveda system- a short report from pakistan’s perspective.wjps Tahir AH, Tanveer M, Ahmed A, Arshad A, Shahnaz G. 2016

World J Pharma

5(12):12-19

(2016)

 

 

18.               Folate grafted thiolated chitosan enveloped nanoliposomes with enhanced oral bioavailability and anticancer activity of docetaxel Sohail MF, Javed I, Hussain SZ, Sarwar HS, Akhtar S, Nadhman A, Batool S, Bukhari NI, Saleem RSZ, Hussain I, Shahnaz G, ,

J Mater Chem B.

ISSN:20507518

4: 6240-6248.

(2016)

 

 

W

     4.543

19.               Annihilation of Leishmania by daylight responsive ZnO nanoparticles: a temporal relationship of reactive oxygen species-induced lipid and protein oxidation Nadhman A, Khan MI, Nazir S, Khan M, Shahnaz G, Raza A, Shams DF, Yasinzai M.  .

Int  J Nanomedicine.

ISSN: 1178-2013

31;11:2451-61.

(2016)

 

 

W

     4.543

20.               Antileishmanial, DNA Interaction, and Docking Studies of Some Ferrocene-Based Heteroleptic Pentavalent Antimonials. Rauf MK, Shaheen U, Asghar F, Badshah A, Nadhman A, Azam S, Ali MI, Shahnaz G, Yasinzai M.

Arch Pharm (Weinheim).

ISSN: 1521-4184

349(1):50-62.

(2016)

 

 

W

     1.994

21.               Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs. Dünnhaupt S, Barthelmes J, Köllner S, Sakloetsakun D, Shahnaz G, Düregger A, Bernkop-Schnürch A.

Carbohydr Polym.

ISSN: 0144-8617

6;117:577-84

(2015)

 

W

     4.81

22.               Synthesis, characterization and evaluation of lecithin-based nanocarriers for the enhanced pharmacological and oral pharmacokinetic profile of amphotericin B, J Mater Chem B Javed I, Hussain SZ, Ullah I, Khan I, Ateeq M, Shahnaz G, Rehman H, Razi MT, Shah MR, Hussain I,.

J Mater Chem B.

ISSN:20507518

3 (42), 8359-8365, (2015)

 

 

W

     4.543

23.               PEGylated silver doped zinc oxide nanoparticles as novel photosensitizers for photodynamic therapy against Leishmania. Nadhman A, Nazir S, Khan MI, Arooj S, Bakhtiar M, Shahnaz G, Yasinzai M.

Free Radic Biol Med.

ISSN: 1873-4596

77:230-8

(2014)

 

       W

     5.736

24.               Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives. Yasinzai M, Khan M, Nadhman A, Shahnaz G.

Future Med Chem.

ISSN: 1756-8927

5(15):1877-88.

(2013)

 

        W

     3.556

25.               Development and in vitro evaluation of slippery nanoparticles for enhanced diffusion through native mucus. Laffleur F, Hintzen F, Shahnaz G, Rahmat D, Leithner K, Bernkop-Schnürch A.

Nanomedicine (Lond).

9(3):387-96.

(2014)

 

 

         W

     4.727

26.               Design and in vitro evaluation of a novel polymeric excipient for buccal applications Laffleur F, Shahnaz G, Islambulchilar Z, Bernkop-Schnürch A..

Future Med Chem.

ISSN: 1756-8927

5(5):511-22

(2013)

      

       W

     3.556

27.               Development of thiolated poly(acrylic acid) microparticles for the nasal administration of exenatide, Millotti GVetter ALeithner KSarti FShahnaz  GAugustijns PBernkop-Schnürch A.

Drug Dev Ind Pharm.

ISSN: 1520-5762

40(12):1677-82

(2014)

      

       W

     2.101

28.               Organotin(IV) complexes of carboxylate derivative as potential chemotherapeutic agents against Leishmania.Qureshi QAH, Nadhman A, Sirajuddin M, Shahnaz GAli S,  Shah A,  Yasinzai M,  

Inorganica Chimica Acta

ISSN: 0020-1693

423 :Part B220-228.

(2014)

       

      W

     2.064

29.               Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles. Shahnaz G, Kremser C, Reinisch A, Vetter A, Laffleur F, Rahmat D, Iqbal J, Dünnhaupt S, Salvenmoser W, Tessadri R, Griesser U, Bernkop-Schnürch A.

Eur J Pharm Biopharm.

ISSN: 1873-3441

85(3 Pt A):346-55.

(2013)

     

 

      W

     4.159

30.               Thiolated hydroxyethyl cellulose: design and in vitro evaluation of mucoadhesive  and permeation enhancing nanoparticles Rahmat D, Müller C, Barthelmes J, Shahnaz G, Martien R, Bernkop-Schnürch A..

Eur J Pharm Biopharm.

ISSN: 1873-3441

83(2):149-55

 

 

 

       W

     4.159

31.               Enzymatic degradation of thiolated chitosan. Laffleur F, Hintzen F, Rahmat D, Shahnaz G, Millotti G, Bernkop-Schnürch A

Drug Dev Ind Pharm.

ISSN: 1520-5762

39(10):1531-9

(2013)

      W

     2.101

32.               HEC-cystamine particles: influence of particle size, zeta potential, morphology and sulfhydryl groups on permeation enhancing properties Rahmat D, Müller C, Shahnaz G, Leithner K, Laffleur F, Khan MI, Martien R, Bernkop Schnürch A..

Drug Dev Ind Pharm.

ISSN: 1520-5762

39(9):1338-45

(2013)

    W

     2.101

33.               A. Thiomers: influence of molar mass on in situ gelling properties. Hintzen F, Laffleur F, Sarti F, Shahnaz G, Bernkop-Schnürch

Int J Pharm.

ISSN: 1873-3476

436(1-2):120-6.

(2012)

W

3.694

34.               Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Shahnaz G, Vetter A, Barthelmes J, Rahmat D, Laffleur F, Iqbal J, Perera G, Schlocker W, Dünnhaput S, Augustijns P, Bernkop-Schnürch A.

Int J Pharm.

ISSN: 1873-3476

428(1-2):164-70

(2012)

 

W

3.694

35.               Synergistic effects of conjugating cell penetrating peptides and thiomers on non-viral transfection efficiency. Rahmat D, Khan MI, Shahnaz G, Sakloetsakun D, Perera G, Bernkop-Schnürch A.

Biomaterials

ISSN: 0142-9612

33(7):2321-6

(2012)

W

8.402

36.               Preactivated thiomers as mucoadhesive polymers for drug delivery. Iqbal J, Shahnaz G, Dünnhaupt S, Müller C, Hintzen F, Bernkop-Schnürch A.

Biomaterials

ISSN: 0142-9612

33(5):1528-35

(2012)

W

     8.402

37.               HEC-cysteamine conjugates: influence of degree of thiolation on efflux pump inhibitory and permeation enhancing properties Rahmat D, Sakloetsakun D, Shahnaz G, Sarti F, Laffleur F, Schnürch AB..

Int J Pharm.

ISSN: 1873-3476

17;422(1-2):40-6

(2012)

W

     3.694

38.               Development and in vivo characterization of a novel peptide drug delivery system providing extended plasma half-life Shahnaz G, Iqbal J, Rahmat D, Perera G, Laffleur F, Rossi D, Bernkop-Schnürch A..

J Control Release.

ISSN: 0168-3659

157(3):375-82.

(2012)

W

     7.786

39.               Poly(acrylic acid)-cysteine for oral vitamin B12 delivery Sarti F, Iqbal J, Müller C, Shahnaz G, Rahmat D, Bernkop-Schnürch A.

Anal Biochem.

ISSN: 0003-2697

420(1):13-9

(2012)

W

     2.334

40.               Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.Iqbal J, Shahnaz G, Perera G, Hintzen F, Sarti F, Bernkop-Schnürch A.

Eur J Pharm Biopharm.

80(1):95-102

(2012)

     W

     4.159

41.               Design and synthesis of a novel cationic thiolated polymer Rahmat D, Sakloetsakun D, Shahnaz G, Perera G, Kaindl R, Bernkop-Schnürch A. 

Int J Pharm.

ISSN: 1873-3476

411(1-2):10-7

(2011)

W

     3.694

42.               Uptake of phenothiazines by the harvested chylomicrons ex vivo model: influence of self-nanoemulsifying formulation design Shahnaz G, Hartl M, Barthelmes J, Leithner K, Sarti F, Hintzen F, Rahmat D, Salvenmoser W, Bernkop-Schnürch A..

Eur J Pharm Biopharm.

79(1):171-80

(2011)

     W

     4.159

43.               Microencapsulation of Diclofenac Sodium by Non-solvent Addition Technique Murtaza G, Ahmad M, Shahnaz G..

Trop J Pharm Res

ISSN: 1596-9827

9(2):187-195

(2010)

      W

     0.569

44.               Synthesis, characterization, mucoadhesion and biocompatibility of thiolated carboxymethyl dextran-cysteine conjugate.Shahnaz G, Perera G, Sakloetsakun D, Rahmat D, Bernkop-Schnürch A.

 

J Control Release.

ISSN: 0168-3659

21;144(1):32-8

(2010)

W

     7.786

                                                        

1)       Conference on "5th Annual Meeting Center for Molecular Biosciences (CMBI)" 26th – 27th 2008, Igls, Tyrol, Austria

2)       Conference on "Life Science Meeting" 18th -19th September 2009, Igls, Tyrol, Austria

3)       Conference on "EuroNanoMedicine" 28th – 30th September 2009, Bled, Slovenia

4)       Conference on "6th Meeting of the Doctoral students from Innsbrucks Medical University and of the life sciences disciplines of the Leopold-Franzens Universitat Innsbruck" 24th November, 2010, Innsbruck, Austria

5)       Conference on "2nd Annual Meeting for Life Sciences" 24th -25th 2010 September, Igls, Tyrol, Austria

6)       Conference on "Joint Meeting of the Austrian and German Pharmaceutical Societies" 20th -23rd September, 2011, Innsbruck, Austria

7)       Conference on "3rd International Conference on Drug Discovery and Therapy (ICDDT)" 7th -10th February 2011, Dubai, UAE

8)       Conference on "7th Meeting of the Doctoral students from Innsbrucks Medical University and of the life sciences disciplines of the Leopold-Franzens Universitat Innsbruck" 11th November 2011, Innsbruck, Austria

9)       17th International Pharmacy Conference & Exhibition, 19th – 21th September 2012, Islamabad, Pakistan

10)   Conference on "9th Biennial International Conference of Pakistan Society for Microbiology" Karachi 28th -31th January, 2013,Karachi, Pakistan

11)   Engaging Private Pharmacies in TB Care & Control - Training Workshop,  15th  July, 2013, Network of Development Professionals, Islamabad, Pakistan

12)   1st International conference on Drug Development- Natural & Synthetic, 25th  - 27th  August, 2013, Comsats-Abbottabad, Pakistan

13) International Symposium on Nanomaterials. "Nanomaterials – Potential Applications & Challenges, 31th  October, 2013, Lahore University of Management Sciences, Lahore, Pakistan

14)   18th International Pharmacy Conference & Exhibition, 31th October 2nd November, 2013, Pakistan Pharmacist Association, Lahore, Pakistan.

15)   Promoting Research and Publication in Pharmaceutical Policy and Practice 20th December 2013 Health Services Academy, Islamabad, Pakistan

16)   Recent Advances in Nanotechnology,   January 6, 2014, PINSAT, Preston University Islamabad

17)   For Women in Science Week, 16th -20th March, 2014, UNESCO head office, Paris, France

18)   Good Governance for Medicines (GGM),21th – 23th April,  World Health Organization Lahore, Pakistan

19)   Pharmaceutical Sector Assessment Survey - Level II, 15th -17th September 2014,World Health Organization,  Islamabad, Pakistan

20)   2nd International Workshop Pharmacy Practice/Clinical Pharmacy,15th -19th December 2014,Quaid-i-Azam ,  Islamabad, Pakistan

21)   Sixth Structural Biology & Molecular Biophysics Workshop,9th July 2015, University of Nebraska Medical Center(UNMC),  Durham Research Center ,Omaha, USA

22)   Seminaraqa on Adventures in the Small World: A Novel Approach to Understanding Intracellular Events During HIV-1 Infection of the CNS, 17th July 2015, University of Nebraska Medical Center (UNMC), Eppley Science Hall, Omaha, USA

23)   Seminar on Hybridtides and the Artisan Biology platform - Towards oral delivery and novel therapeutic mechanisms 28th July 2015, University of Nebraska Medical Center(UNMC),  Durham Research Center ,Omaha, USA

24)   International Nanomedicines Symposium on Nanotheranostics, 26th November 2015, NORI, Islamabad

25)   International Symposium, Nanomedicines: Development, Testing and Application Possibilities, 1st March 2016, NORI, Islamabad  

26)   ISESCO Women in Science Conference on Contributions of Pakistani Women in Scientific and Social Development2, 8th March 2016, QAU, Islamabad

27)   Regional Workshop On Biosafety and Biosecurity for Life Sciences Researchers, 26th -27th April, 2016 Pakistan Academy of Sciences, Islamabad

28)   3rd Conference on Frontiers of Nanoscience and Nanotechnology,25th October 2016, PINSTECH, Islamabad.

29)   4th conference on Frontiers of Nanoscience and Nanotechnology, 12-13 December, 2017 PINSTECH, Islamabad

30)   Research protocol development workshop for Implementation research, 9-12 May 2017 Health Services Academy, Islamabad 

31)   2nd International Workshop on Experimental Biology-IWEB-2017 “Nanotheranostics: From Bench to Bedside and Beyond”22-24 November 2017, NILOP, Islamabad               

National Workshop “Nanomedicine; Advancements and Challenges in Pakistan” November 27-29, 2017 Department of Pharmacy, Quaid-i-Azam University, Islamabad

1.       "Comparative bioavailability & pharmacokinetic characterization of phenothiazines by using self-nanoemulsifying drug delivery system" (0.5 million) By: Higher Education Commission, Pakistan ( Completed; 2012-2013) P.I (Dr. Gul Shahnaz) Co-PI ( Dr. Gul Majid Khan)

2.       Nanoparticles based on Thiolated Polymeric Excipients: Promising Tool for Amphotericin B Drug Delivery in Leishmaniasis Therapy” (34,000 Pk/Rs.)  By: URF,Quaid-i-Azam University ( Completed; 2012) P.I (Dr. Gul Shahnaz)

3.       Mucoadhesive In Situ Gel based on Thiomeric Excipients: Novel Strategy for Leishmaniasis Drug Delivery   (24,000 Pk/Rs)   By: URF,Quaid-i-Azam University( Completed; 2013)  P.I (Dr. Gul Shahnaz)  

4.        Monocyte-macrophage as targeted drug depots for long acting anti-microbial medicines (20,000 US dollars)  By:  L’Oréal-UNESCO (Completed; 2014-2015) P.I (Dr. Gul Shahnaz)

5.       Synthesis and characterization of Polyethyleneimine-g-Poly(caprolactone-co-lactic acid) for the control release of drugs (50,000 Pk/Rs)  By: URF,Quaid-i-Azam University ( Completed; 2014) P.I (Dr. Gul Shahnaz)

6.       Synthesis and characterization of Polyethyleneimine-g-Chitosan nanoparticles for drug delivery (100,000 Pk/Rs)  By: URF,Quaid-i-Azam University ( Completed; 2015) P.I (Dr. Gul Shahnaz)

7.       Evaluation of mannose-anchored thiolated nanocarriers for improved oral bioavailability of amphotericin B against leishmaniasis therapy (20,000 US dollars)   By:  L’Oréal-UNESCO (Approved for 2015-2016) P.I (Dr. Gul Shahnaz)

8.       Development and evaluation of mannose-anchored thiolated nanocarriers for leishmaniasis therapy By:   COMSTECH-TWAS (4,400 US dollars) (Approved for 2016-2017) P.I (Dr. Gul Shahnaz)

9.       Synthesis and characterization of a disulfide cross-linked multifunctional in situ gelling cargo for oral peptide drug delivery  By:   Pakistan Academy of Sciences (0.927 Millions)  (Approved for 2016-2018) P.I (Dr. Gul Shahnaz)

10.    Development of Thiolated Polymer Coated Gel: Promising Platform for Controlled and Targeted Drug Delivery in Leishmaniasis  By:   Higher Education Commission, Pakistan (14.5 Millions)  (Approved for 2016-2019) Co-P.I (Dr. Gul Shahnaz), P.I (Dr. Gul Majid Khan)

11.   Synthesis and Evaluation of Doped Phototoxic Nanoparticles based Topical Skin-care Cream as a Novel, Cheap Substitute to Current Treatment for Leishmania Infection  By:   Pakistan Science Foundation (7 Millions)  (Approved for 2015-2018) Co-P.I (Dr. Gul Shahnaz), P.I (Prof. Dr. Masoom Yasinzai)



Quaid-i-Azam University Islamabad, 45320, Pakistan.
Tel: +92-51 9064 0000, Email:webmaster@qau.edu.pk